Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 3
1980 4
1981 18
1982 6
1983 28
1984 19
1985 46
1986 39
1987 45
1988 28
1989 39
1990 30
1991 27
1992 37
1993 32
1994 27
1995 22
1996 36
1997 20
1998 34
1999 12
2000 16
2001 9
2002 19
2003 18
2004 17
2005 17
2006 15
2007 17
2008 24
2009 20
2010 21
2011 25
2012 17
2013 9
2014 17
2015 14
2016 9
2017 8
2018 7
2019 13
2020 9
2021 3
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

854 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Single Dose Premedication of Piroxicam and Prednisolone on Post Endodontic Pain in One Visit Root Canal Treatment: A Randomized Clinical Trial.
Tanwir A, Ahmed S, Akhtar H, Wahid U, Shakoor Abbasi M, Ahmed N. Tanwir A, et al. Eur Endod J. 2022 Oct;7(3):187-192. doi: 10.14744/eej.2022.24119. Eur Endod J. 2022. PMID: 36217645 Free PMC article. Clinical Trial.
OBJECTIVE: The objective of this study was to compare the effectiveness of premedication drugs including single dose Piroxicam and Prednisolone in regard to post endodontic pain at different time intervals (24, 48, 72 and 96 hours) after single visit root canal treatment. …
OBJECTIVE: The objective of this study was to compare the effectiveness of premedication drugs including single dose Piroxicam and Pr …
Clinical trial of long-acting oxytetracycline and piroxicam in the treatment of canine ehrlichiosis.
Adawa DA, Hassan AZ, Abdullah SU, Ogunkoya AB, Adeyanju JB, Okoro JE. Adawa DA, et al. Vet Q. 1992;14(3):118-20. doi: 10.1080/01652176.1992.9694345. Vet Q. 1992. PMID: 1413442 Clinical Trial.
In order to eliminate pain at the site of injection of TLA, varying doses of piroxicam were administered intramuscularly to the treated dogs. A minimum of 15 mg of piroxicam proved effective in eliminating pain and swelling at the TLA-injection sites, while fever wa …
In order to eliminate pain at the site of injection of TLA, varying doses of piroxicam were administered intramuscularly to the treat …
Worldwide studies comparing piroxicam and naproxen.
Plantema F. Plantema F. Acta Obstet Gynecol Scand Suppl. 1986;138:15-7. doi: 10.3109/00016348509157061. Acta Obstet Gynecol Scand Suppl. 1986. PMID: 3548206 Review.
In double-blind, crossover studies, piroxicam was compared with naproxen. Piroxicam 40 mg was given once daily for two days, followed by 20 mg once daily and is compared with naproxen 750 mg daily for two days, followed by 500 mg daily (N = 85) and with naproxen 1,0 …
In double-blind, crossover studies, piroxicam was compared with naproxen. Piroxicam 40 mg was given once daily for two days, f …
Piroxicam: new dosage forms.
Norris E, Guttadauria M. Norris E, et al. Eur J Rheumatol Inflamm. 1987;8(1):94-104. Eur J Rheumatol Inflamm. 1987. PMID: 3305038 Clinical Trial.
(Ed.: The parenteral and topical formulations were launched after the symposium was held, and are now available). The piroxicam suppository offers an alternative to the oral route of administration. ...Piroxicam topical gel (0.5%) has been demonstrated to have anti- …
(Ed.: The parenteral and topical formulations were launched after the symposium was held, and are now available). The piroxicam suppo …
A clinical evaluation of flurbiprofen LAT and piroxicam gel: a multicentre study in general practice.
Ritchie LD. Ritchie LD. Clin Rheumatol. 1996 May;15(3):243-7. doi: 10.1007/BF02229701. Clin Rheumatol. 1996. PMID: 8793254 Clinical Trial.
A prospective, randomized, multicentre, open, crossover study of the comparative efficacy, tolerability and acceptability of two topical nonsteroidal anti-inflammatory drug (NSAID) therapies, flurbiprofen local-action transcutaneous (LAT) patch (40 mg b.d.) and piroxicam g …
A prospective, randomized, multicentre, open, crossover study of the comparative efficacy, tolerability and acceptability of two topical non …
Imidazole salicylate versus piroxicam in the treatment of arthrosis in elderly patients. A double-blind clinical and endoscopic trial.
Montrone F, Petrillo M, Ardizzone S, Scaricabarozzi I, Scotti A, Caruso I, Bianchi Porro G. Montrone F, et al. J Am Geriatr Soc. 1990 Sep;38(9):985-8. doi: 10.1111/j.1532-5415.1990.tb04420.x. J Am Geriatr Soc. 1990. PMID: 2212452 Clinical Trial.
After upper gastrointestinal endoscopy for the purpose of excluding gastric and duodenal mucosal lesions, the patients were allocated at random, according to a double-blind, double-dummy protocol, to treatment either with imidazole salicylate 750 mg three times daily or with p
After upper gastrointestinal endoscopy for the purpose of excluding gastric and duodenal mucosal lesions, the patients were allocated at ran …
A clinical trial comparing a new NSAID (droxicam) and piroxicam in spinal osteoarthritis.
Bohl D, Gausmann H, Vorberg G, Sánchez J, García-Barbal R, Sarti JF, Harrison FJ. Bohl D, et al. Int J Clin Pharmacol Ther Toxicol. 1990 Oct;28(10):416-9. Int J Clin Pharmacol Ther Toxicol. 1990. PMID: 2258250 Clinical Trial.
This double-blind, parallel, controlled and randomized trial compares the clinical efficacy and tolerance of a new NSAID (pro-drug of piroxicam), droxicam, at the dose of 20 mg/day against that of piroxicam at the same dose. ...No statistically significant differenc …
This double-blind, parallel, controlled and randomized trial compares the clinical efficacy and tolerance of a new NSAID (pro-drug of pir
Efficacy and tolerability of tenoxicam--an overview.
Vischer TL. Vischer TL. Scand J Rheumatol Suppl. 1987;65:107-12. Scand J Rheumatol Suppl. 1987. PMID: 3317800 Review.
Most trials comparing tenoxicam with another NSAID have used piroxicam, an earlier oxicam derivative which also has a long half-life. ...In short-term studies 11% of patients receiving 20 mg tenoxicam and 18% on 40 mg tenoxicam experienced side-effects (p less than 0.01), …
Most trials comparing tenoxicam with another NSAID have used piroxicam, an earlier oxicam derivative which also has a long half-life. …
Efficacy and tolerability of tenoxicam--an overview.
Vischer TL. Vischer TL. Eur J Rheumatol Inflamm. 1987;9(2):51-7. Eur J Rheumatol Inflamm. 1987. PMID: 3329109 Review.
Most trials comparing tenoxicam with another NSAID have used piroxicam, an earlier oxicam derivative which also has a long half-life. ...In short-term studies 11% of patients receiving 20 mg tenoxicam and 18% on 40 mg tenoxicam experienced side-effects (p less than 0.01), …
Most trials comparing tenoxicam with another NSAID have used piroxicam, an earlier oxicam derivative which also has a long half-life. …
Clinical benefits and comparative safety of piroxicam. Analysis of worldwide clinical trials data.
Meisel AD. Meisel AD. Am J Med. 1986 Nov 28;81(5B):15-21. Am J Med. 1986. PMID: 3538866 Clinical Trial.
In response to concerns raised about the safety of piroxicam, Pfizer Inc. has reviewed three sets of data that constitute the largest body of current evidence regarding the efficacy and safety of piroxicam. ...Second, the principal findings of a large Norwegian mult …
In response to concerns raised about the safety of piroxicam, Pfizer Inc. has reviewed three sets of data that constitute the largest …
854 results